American Joint Committee on Cancer Prognostic Factors Consensus Conference: Colorectal Working Group.
about
Colorectal cancer tumour markers and biomarkers: Recent therapeutic advancesPrognostic stratification of colorectal cancer patients: current perspectivesCDX2 as a Prognostic Biomarker in Stage II and Stage III Colon CancerLymphovascular invasion in colorectal cancer: an interobserver variability study.Revised TN categorization for colon cancer based on national survival outcomes data.New intracellular and molecular aspects in pathophysiology of colorectal cancerPrognostic effect of activated EGFR expression in human colon carcinomas: comparison with EGFR statusRevised tumor and node categorization for rectal cancer based on surveillance, epidemiology, and end results and rectal pooled analysis outcomesABCG5-positivity in tumor buds is an indicator of poor prognosis in node-negative colorectal cancer patients.Model-based prediction of defective DNA mismatch repair using clinicopathological variables in sporadic colon cancer patients.Mucinous adenocarcinoma of the rectum: a poor candidate for neo-adjuvant chemoradiation?Clinicopathologic characteristics, surgical treatment and outcomes for splenic flexure colon cancer.Clinical significance of lymph vessel density in T3 colorectal carcinoma.Prognostic impact of bim, puma, and noxa expression in human colon carcinomas.Diagnostic and prognostic tumor markers in the gastrointestinal tract.Tumor budding as a risk factor of lymph node metastasis in submucosal invasive T1 colorectal carcinoma: a retrospective study.Tumor markers in colorectal cancer, gastric cancer and gastrointestinal stromal cancers: European group on tumor markers 2014 guidelines updateCytokeratins and carcinoembryonic antigen in diagnosis, staging and prognosis of colorectal adenocarcinomaPersistent high postoperative carcinoembryonic antigen in colorectal cancer patients--is it important?Review of histopathological and molecular prognostic features in colorectal cancerThe tumor border configuration of colorectal cancer as a histomorphological prognostic indicator.Local massive venous invasion in colorectal cancer: CT-pathological correlation and its clinical implication.Computed tomography and magnetic resonance imaging evaluation of lymph node metastasis in early colorectal cancerHistopathological features predict metastatic potential in locally advanced colon carcinomasRole of blood tumor markers in predicting metastasis and local recurrence after curative resection of colon cancer.Preoperative carcinoembryonic antigen and prognosis of colorectal cancer. An independent prognostic factor still reliable.Ki-ras gene mutations, LOH of the APC and DCC genes, and microsatellite instability in primary colorectal carcinoma are not associated with micrometastases in pericolonic lymph nodes or with patients' survival.Joint prognostic effect of obesity and chronic systemic inflammation in patients with metastatic colorectal cancer.3'-UTR Polymorphisms in the MiRNA Machinery Genes DROSHA, DICER1, RAN, and XPO5 Are Associated with Colorectal Cancer Risk in a Korean Population.Merging claims databases with a tumor registry to evaluate variations in cancer mortality: results from a pilot study of 698 colorectal cancer patients treated at one hospital in the 1990s.Prognostic significance and molecular associations of tumor growth pattern in colorectal cancer.Gene expression profiling for molecular staging and prognosis prediction in colorectal cancer.Tumor micrometastases in mesorectal lymph nodes and their clinical significance in patients with rectal canerPoor survival in stage IIB/C (T4N0) compared to stage IIIA (T1-2 N1, T1N2a) colon cancer persists even after adjusting for adequate lymph nodes retrieved and receipt of adjuvant chemotherapy.Evaluating the quality of colorectal cancer care in the state of Florida: results from the Florida Initiative for Quality Cancer CareIs occult lymph node disease in colorectal cancer patients clinically significant? A review of the relevant literature.The clinicopathological features of colorectal mucinous adenocarcinoma and a therapeutic strategy for the disease.Florida Initiative for Quality Cancer Care: improvements on colorectal cancer quality of care indicators during a 3-year interval.Histopathology and enhanced detection of tumor invasion of peritoneal membranes.Expression of Folate Pathway Genes in Stage III Colorectal Cancer Correlates with Recurrence Status Following Adjuvant Bolus 5-FU-Based Chemotherapy.
P2860
Q26768427-35B1A278-DFF3-4C8F-97F5-6962A962F8D3Q26823543-7F5D2D64-DE43-45E2-B8E2-BDB1F6BEBDF8Q27853326-5720BC57-99F1-48BA-8BC5-CB300A58E299Q33367917-DB80467D-7CE7-4631-AAA2-0D32E9AAE8A3Q33516922-A2F8011E-1603-4F6F-AA3A-DD2037466DE7Q33596234-E4E427D5-F2ED-48BE-ADDA-9F6762E8F095Q33620091-CCEC89CA-FA9B-4389-81A9-2E9FE4EAB13FQ33627785-075C16CA-F526-4BC3-9F9C-51C09CC14338Q33632359-E8AF090C-958E-4ACB-843F-0D041BDE3D0BQ33792250-9C0634E3-810A-4E83-B90B-8B1D8045BE3FQ33948014-515B3EAF-912A-4F71-8559-E737E75CDBBEQ33980012-7DCE572A-BC57-4299-A10C-5CB35DEE3EE0Q34121492-35A466A7-5CC3-4F9A-971B-82AB786717FDQ34167987-8B288C56-0DF1-4892-8ADF-123CDD571BE5Q34277292-8262C1E9-017F-47EF-858A-FABA75583A97Q34367365-DEB6351D-5DF5-4266-B51C-8EC569E0DB4BQ34441837-D1AF080C-04E1-46E0-8365-216A2E15324EQ34605362-3C754D7A-8F7C-43ED-970E-8299E460436EQ34608433-AF430160-C117-40E0-B63E-5199F3C77968Q34657323-E23E3A17-F95B-4AB1-9ACC-8FB3580457C9Q34660196-9FCD6953-CEE4-40E9-BB53-D3B9B79AB8A8Q34776505-28CF976F-2991-4EF7-A6AF-005284A3E5E6Q34954667-FB82ABDD-3921-4E4D-BF4A-6363D02092FFQ35016109-DE0C1D4A-8D53-49E9-BCD7-E3A1AAE08DD4Q35173691-D4C288AC-E9CF-4789-9A8C-B47C6591DC37Q35456960-861C9EA8-74EE-4AEF-9C1B-7526B9DD73FDQ35587940-10E9F48D-7DA6-4E44-9E2E-FCA696E5497DQ35632071-D23530BA-B91E-4453-8561-67C1FA744AE5Q35683457-B8AB31AC-C44E-4EFE-9345-4911F4A43C9BQ35806743-432F4CAE-5BF4-4D67-A4AF-17B4DACD2F6DQ35874805-D717C3B5-B36D-45D3-9A47-20B0770283EEQ35878266-66424D71-5979-4511-A8EF-66E86ABC6BD9Q36066155-D72E1ECA-DF0E-429E-A234-8384BDF00BD3Q36076656-9281869A-EE05-42C5-B1C1-F481FE140AF8Q36095244-87F5B049-429A-43F6-9F37-99186FF05EBCQ36103437-1660CB1B-4DA3-4C17-847E-D31BBC7E00EEQ36125311-800F5F9C-A894-425C-B442-9918163BDCA4Q36275365-D98612E5-B7D8-4C52-BA91-F9A7B8B5CFC9Q36304484-6E309EDF-F316-4A16-B33B-9C02C0C23049Q36307888-8A85EABF-4524-4AFE-A435-EC2421E1D04B
P2860
American Joint Committee on Cancer Prognostic Factors Consensus Conference: Colorectal Working Group.
description
2000 nî lūn-bûn
@nan
2000 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
American Joint Committee on Ca ...... nce: Colorectal Working Group.
@ast
American Joint Committee on Ca ...... nce: Colorectal Working Group.
@en
type
label
American Joint Committee on Ca ...... nce: Colorectal Working Group.
@ast
American Joint Committee on Ca ...... nce: Colorectal Working Group.
@en
prefLabel
American Joint Committee on Ca ...... nce: Colorectal Working Group.
@ast
American Joint Committee on Ca ...... nce: Colorectal Working Group.
@en
P2093
P2860
P1433
P1476
American Joint Committee on Ca ...... nce: Colorectal Working Group.
@en
P2093
Fenoglio-Preiser CM
Fielding LP
Pettigrew N
P2860
P304
P356
10.1002/(SICI)1097-0142(20000401)88:7<1739::AID-CNCR30>3.0.CO;2-T
P407
P577
2000-04-01T00:00:00Z